The American Institute for Medical and Biological Engineering (AIMBE), a non-profit organization consisting of the most accomplished individuals in the fields of medical and biological engineering, has announced the election of the 2022 class of AIMBE Fellows. Two professionals from the Biophysical Society of China (BSC) were among the eight Chinese nominees to its College of Fellows.

Ma Guanghui

Academician with the Chinese Academy of Sciences (CAS)

Director of the State Key Laboratory of Biochemical Engineering at the Institute of Process Engineering of the CAS

Member of the BSC

Research interests: Ma specializes in the manufacturing of uniform bio-microspheres and bio-microcapsules and their applications in biochemical and biomedical engineering, and research and development of innovative products for biochemical separation, drug delivery, immune adjuvants (vaccine delivery systems) and microcarriers for cell culture.

Ma has published more than 400 SCI papers in such renowned academic journals as Nature Materials and Nature Nanotechnology and her works have been cited over 13,000 times. She has published 12 monographs in Chinese and English and written 22 chapters of academic literature, including Perry's Chemical Engineer's Handbook. She was the first Chinese scholastic writer to participate in the composition of the book.

Ma has obtained 88 Chinese invention patents and 12 international patents,which have been applied by more than 500 institutions in China and abroad. She has won multiple awards and honorary titles such as the second prize of the National Technology Invention Award, the first prize of the Beijing Municipal Science and Technology Awards and CAST national outstanding scientific and technological worker.

Achievements

Ma has made outstanding contributions to biological engineering through innovative membrane emulsification technology and particulate system designs of biomedical formulations.

Nie Guangjun

Research fellow of the National Center for Nanoscience and Technology

Distinguished researcher at the CAS

Distinguished professor of the University of the Chinese Academy of Sciences

President of the BSC Academic Subgroup of Material Biology and Intelligent Diagnosis and Treatment Technology

Research interests: Tumor nanobiology, nanobiotechnology and nano biological effects

Nie won the 2016 Chinese Pharmaceutical Association Yiling Biomedical Youth Award and was recruited as a part-time professor at the Houston Methodist Research Institute. He was also named  advanced Newton scholar by the Academy of Medical Sciences.

Nie has published more than 140 papers on Nature Biotechnology and Nature Biomedical Engineering. His works on antitumor application have supported 20 Chinese patents, three US patents, one Japanese patent and two patent assignments, and been recommended and reported by Nature Biotechnology and Nature Materials.

Achievements

Nie has made outstanding contributions to the development of cancer nanomedicines for regulation of tumor microenvironments and intelligent antitumor nanorobots.

AIMBE Fellows are nominated each year by their peers and represent the top two percent of medical and biological engineers. The title marks the highest academic honor in medicine and bioengineering technologies in the United States. To date, more than 2,000 scholars have been selected as AIMBE Fellows.